Evidence suggests the use of neuroimaging to detect therapeutic effects of anxiolytic treatment when appropriate cognitive-emotional tasks are use to activate the emotional brain neurocircuitry believed to be involved in the core symptoms of the disease.

Inclusion criteria:

• Primary diagnosis of Social Anxiety Disorder.
• Willing to restrict alcohol to a limited intake.

Exclusion criteria:

• History of schizophrenia, schizoaffective disorder or a bipolar disorder.
• Left-handed.
• Suffer from claustrophobia.
• Any reason why subject could not go into the fMRI, for example have metal implants.